Published in Genetics on June 01, 1979
Modulation of protein levels in chromosomal dosage series of maize: the biochemical basis of aneuploid syndromes. Genetics (1981) 1.99
Quantitative trait loci underlying gene product variation: a novel perspective for analyzing regulation of genome expression. Genetics (1994) 1.74
Population genetics of Drosophila amylase. IV. Selection in laboratory populations maintained on different carbohydrates. Genetics (1983) 1.11
Genetic Analysis of Natural Populations of DROSOPHILA MELANOGASTER in Japan. III. Genetic Variability of Inducing Factors of Amylase and Fitness. Genetics (1984) 0.96
Nonrandom Association between Structural Amy and Regulatory map Variants in DROSOPHILA MELANOGASTER. Genetics (1986) 0.81
Population genetics of Drosophila amylase. V. Genetic background and selection on different carbohydrates. Genetics (1984) 0.75
Genetic variation in natural populations: patterns and theory. Theor Popul Biol (1978) 3.08
Enzyme variability in the Drosophila willistoni group. IV. Genic variation in natural populations of Drosophila willistoni. Genetics (1972) 9.38
Intraspecific nuclear DNA variation in Drosophila. Mol Biol Evol (1996) 6.29
Polymorphisms in continental and island populations of Drosophila willistoni. Proc Natl Acad Sci U S A (1971) 6.28
The objective evaluation of dysmenorrhea therapy. Am J Obstet Gynecol (1980) 4.38
Interspecific cytoplasmic gene flow in the absence of nuclear gene flow: evidence from Drosophila. Proc Natl Acad Sci U S A (1983) 2.95
Codon usage bias and tRNA abundance in Drosophila. J Mol Evol (1997) 2.77
Speciation within Anopheles gambiae--the glass is half full. Science (2002) 2.41
Evidence for selection by male mating success in natural populations of Drosophila pseudoobscura. Proc Natl Acad Sci U S A (1979) 2.38
Gene length and codon usage bias in Drosophila melanogaster, Saccharomyces cerevisiae and Escherichia coli. Nucleic Acids Res (1998) 2.37
Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia. Am Rev Respir Dis (1978) 2.28
Inhibition of theophylline clearance by cimetidine but not ranitidine. Arch Intern Med (1984) 2.17
Analysis of bacterial function by multi-colour fluorescence flow cytometry and single cell sorting. J Microbiol Methods (2000) 2.13
Rates and patterns of scnDNA and mtDNA divergence within the Drosophila melanogaster subgroup. Genetics (1988) 2.06
Genetic polymorphisms in varied environments. Science (1971) 2.04
Attempts to molecularly distinguish cryptic taxa in Anopheles gambiae s.s. Insect Mol Biol (2001) 2.02
Temperature related genetic divergence in Drosophila body size. J Hered (1974) 1.94
Enzyme variability in the Drosophila Willistoni group. V. Genic variation in natural populations of Drosophila equinoxialis. Genet Res (1972) 1.92
Allozymes as diagnostic characters of sibling species of Drosophila. Proc Natl Acad Sci U S A (1972) 1.75
Inadequately written prescriptions. "As directed" prescriptions analyzed. JAMA (1973) 1.71
Selective introgression of paracentric inversions between two sibling species of the Anopheles gambiae complex. Genetics (1997) 1.70
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006. Clin Pharmacol Ther (2007) 1.70
Genetics and the origin of a vector population: Aedes aegypti, a case study. Science (1980) 1.67
Evidence of heterosis associated with an enzyme locus in a natural population of Drosophila. Proc Natl Acad Sci U S A (1970) 1.64
Oral infection of Aedes aegypti with yellow fever virus: geographic variation and genetic considerations. Am J Trop Med Hyg (1985) 1.58
Apparent selection of enzyme alleles in laboratory populations of Drosophila. Genetics (1973) 1.54
Codon usage and the origin of P elements. Mol Biol Evol (1996) 1.52
Molecular phylogeny of the Anopheles gambiae complex suggests genetic introgression between principal malaria vectors. Proc Natl Acad Sci U S A (1994) 1.48
A world-wide survey of genetic variation in the yellow fever mosquito, Aedes aegypti. Genet Res (1979) 1.47
Identification and specific blockade of two receptors for histamine in the cardiovascular system. J Pharmacol Exp Ther (1976) 1.47
The genetics of inviability and male sterility in hybrids between Anopheles gambiae and An. arabiensis. Genetics (2004) 1.42
Inbreeding and mating patterns in Drosophila pseudoobscura. Behav Genet (1979) 1.34
Enzyme variability in the Drosophila willistoni group. VI. Levels of polymorphism and the physiological function of enzymes. Biochem Genet (1972) 1.34
Microgeographic differentiation of chromosomal and enzyme polymorphisms in Drosophila persimilis. Genetics (1977) 1.31
Evolution of the mitochondrial DNA control region in the Anopheles gambiae complex. Insect Mol Biol (1996) 1.31
Flounder effects and linkage disequilibria in experimental populations of Drosophila. Proc Natl Acad Sci U S A (1974) 1.31
Synonymous substitution rates in Drosophila: mitochondrial versus nuclear genes. J Mol Evol (1997) 1.30
Human plasminogen. Methods Enzymol (1981) 1.26
Rates of nucleotide substitution in Drosophila mitochondrial DNA and nuclear DNA are similar. Proc Natl Acad Sci U S A (1986) 1.24
The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis (1977) 1.21
Phylogeny of all major groups of cetaceans based on DNA sequences from three mitochondrial genes. Mol Biol Evol (1994) 1.20
Origin and evolutionary relationships of giant Galápagos tortoises. Proc Natl Acad Sci U S A (1999) 1.20
Cimetidine decreases theophylline clearance. Am Rev Respir Dis (1981) 1.19
Inversion monophyly in African anopheline malaria vectors. Genetics (1996) 1.15
Mitochondrial DNA rates and biogeography in European newts (genus Euproctus). Syst Biol (1997) 1.14
Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults. J Pharmacokinet Biopharm (1982) 1.14
Reassociation kinetics of Anopheles gambiae (Diptera: Culicidae) DNA. J Med Entomol (1992) 1.14
Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase. Infect Immun (1994) 1.14
Regulation of the segmentation gene fushi tarazu has been functionally conserved in Drosophila. EMBO J (1990) 1.13
Multiple origins of cytologically identical chromosome inversions in the Anopheles gambiae complex. Genetics (1998) 1.12
Population genetics of Drosophila amylase. IV. Selection in laboratory populations maintained on different carbohydrates. Genetics (1983) 1.11
Population genetics of Drosophila amylase. II. Geographic patterns in D. pseudoobscura. Genetics (1979) 1.11
A molecular phylogeny for the Drosophila melanogaster subgroup and the problem of polymorphism data. Mol Biol Evol (1996) 1.10
Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. Clin Pharmacol Ther (1992) 1.09
Rates of dispersal of Drosophila pseudoobscura and its relatives. Proc R Soc Lond B Biol Sci (1974) 1.07
Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am J Clin Nutr (2001) 1.06
Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. Am J Med (1984) 1.06
Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol. J Cardiovasc Pharmacol (1987) 1.05
Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr (2001) 1.05
Extreme rates and heterogeneity in insect DNA evolution. J Mol Evol (1990) 1.03
Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of beta-adrenergic receptor, adenylate cyclase, and ventricular contraction. Endocrinology (1979) 1.01
A molecular phylogeny of four endangered Madagascar tortoises based on MtDNA sequences. Mol Phylogenet Evol (1999) 1.00
Clinical pharmacology of carvedilol in normal volunteers. Clin Pharmacol Ther (1987) 0.98
Genetics of natural populations, XLIII. Further studies on rates of dispersal of Drosophila pseudoobscura and its relatives. Genetics (1976) 0.98
Phylogeny of species of Triatoma (Hemiptera: Reduviidae) based on mitochondrial DNA sequences. J Med Entomol (1998) 0.97
Macrogeographic genetic variation in a human commensal: Aedes aegypti, the yellow fever mosquito. Genet Res (1983) 0.96
Intraspecific DNA divergence in Drosophila: a study on parthenogenetic D. mercatorum. Mol Biol Evol (1987) 0.95
Venous irritation related to intravenous administration of phenytoin versus fosphenytoin. Pharmacotherapy (1994) 0.95
LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol (1995) 0.95
Monophyly/paraphyly/polyphyly and gene/species trees: an example from Drosophila. Mol Biol Evol (1991) 0.94
Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci (Lond) (2001) 0.94
Therapeutic problems of ulcerative colitis with hyperthyroidism. Am J Gastroenterol (1968) 0.93
Higher level relationships of the arctoid Carnivora based on sequence data and "total evidence". Mol Phylogenet Evol (1994) 0.93
Evolution of the Adh locus in the Drosophila willistoni group: the loss of an intron, and shift in codon usage. Mol Biol Evol (1993) 0.93
Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-Davis. Clin Pharmacokinet (2000) 0.93
Calibration of the change in thermal stability of DNA duplexes and degree of base pair mismatch. J Mol Evol (1988) 0.92
Heterosis at an enzyme locus of Drosophila: evidence from experimental populations. Heredity (Edinb) (1974) 0.92
Compositional divergence and convergence in arbuscular mycorrhizal fungal communities. Ecology (2012) 0.91
Influence of allopurinol on theophylline disposition in adults. Clin Pharmacol Ther (1980) 0.91
Pharmacokinetics of ondansetron in patients with hepatic insufficiency. J Clin Pharmacol (1996) 0.90
The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications. J Clin Gastroenterol (1983) 0.90
Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan. Pharmacotherapy (1996) 0.90
Interspecific and intraspecific comparisons of the period locus in the Drosophila willistoni sibling species. Mol Biol Evol (1997) 0.89
More on heparin lock. N Engl J Med (1977) 0.89
Prolonged vitamin C supplementation and recovery from demanding exercise. Int J Sport Nutr Exerc Metab (2001) 0.88
Concordance of arthritis and iritis in identical twins with ulcerative colitis. J Natl Med Assoc (1974) 0.88
Characterization of vascular histamine receptors in the rat. Br J Pharmacol (1979) 0.88
Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria. J Pharmacokinet Biopharm (1980) 0.88
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines. J Med Chem (1988) 0.87
Carotid sinus reflex coronary vasoconstriction during controlled myocardial oxygen metabolism in the dog. Circ Res (1979) 0.87
The existence of independent domain structures in human Lys77-plasminogen. J Biol Chem (1981) 0.87
Effects of histamine on vascular sympathetic neuroeffector transmission. J Pharmacol Exp Ther (1979) 0.87
Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442. J Biol Chem (1980) 0.87
Melittin and phospholipase A2 from bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo. Toxicon (1997) 0.87
Complementary DNA-DNA hybridization in Drosophila. J Mol Evol (1992) 0.86
Long-distance genome walking using the long and accurate polymerase chain reaction. Biotechniques (1998) 0.86
Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension (1995) 0.85
Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time. Pharm Res (1993) 0.85
Antioxidants may contribute in the fight against ageing: an in vitro model. Mech Ageing Dev (2000) 0.85